Your search returned 5 results.

Results
	1.	The influence of the corticothalamic projection on responses in thalamus and cortex. [electronic resource] by Wörgötter, Florentin Eyding, Dirk Macklis, Jeffrey D Funke, Klaus Producer: 20030501 In: Philosophical transactions of the Royal Society of London. Series B, Biological sciences vol. 357 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Selective elimination of corticogeniculate feedback abolishes the electroencephalogram dependence of primary visual cortical receptive fields and reduces their spatial specificity. [electronic resource] by Eyding, Dirk Macklis, Jeffrey D Neubacher, Ute Funke, Klaus Wörgötter, Florentin Producer: 20030909 In: The Journal of neuroscience : the official journal of the Society for Neuroscience vol. 23 Availability: No items available. Save to lists Add to cart (remove)
	3.	Contrast-enhanced ultrasonic parametric perfusion imaging detects dysfunctional tissue at risk in acute MCA stroke. [electronic resource] by Eyding, Jens Krogias, Christos Schöllhammer, Martin Eyding, Dirk Wilkening, Wilko Meves, Saskia Schröder, Alexandra Przuntek, Horst Postert, Thomas Producer: 20060613 In: Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism vol. 26 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials. [electronic resource] by Eyding, Dirk Lelgemann, Monika Grouven, Ulrich Härter, Martin Kromp, Mandy Kaiser, Thomas Kerekes, Michaela F Gerken, Martin Wieseler, Beate Producer: 20101018 In: BMJ (Clinical research ed.) vol. 341 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset. [electronic resource] by Furlan, Anthony J Eyding, Dirk Albers, Gregory W Al-Rawi, Yasir Lees, Kennedy R Rowley, Howard A Sachara, Christian Soehngen, Mariola Warach, Steven Hacke, Werner Producer: 20060718 In: Stroke vol. 37 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)